V013-3335 Screening compound: N-(2-methoxyethyl)-2-[2-(trifluoromethyl)benzamido]-1,3-thiazole-4-carboxamide

V013-3335 Screening compound: N-(2-methoxyethyl)-2-[2-(trifluoromethyl)benzamido]-1,3-thiazole-4-carboxamide
V013-3335 Screening compound: N-(2-methoxyethyl)-2-[2-(trifluoromethyl)benzamido]-1,3-thiazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V013-3335
N-(2-methoxyethyl)-2-[2-(trifluoromethyl)benzamido]-1,3-thiazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V013-3335

Molecular Formula

C15H14F3N3O3S (C15 H14 F3 N3 O3 S)

Compound Name

N-(2-methoxyethyl)-2-[2-(trifluoromethyl)benzamido]-1,3-thiazole-4-carboxamide

IUPAC name

N-(2-methoxyethyl)-2-[2-(trifluoromethyl)benzamido]-13-thiazole-4-carboxamide

SMILES

COCCNC(c1csc(NC(c2c(C(F)(F)F)cccc2)=O)n1)=O

InChI

InChI=1S/C15H14F3N3O3S/c1-24-7-6-19-13(23)11-8-25-14(20-11)21-12(22)9-4-2-3-5-10(9)15(16,17)18/h2-5,8H,6-7H2,1H3,(H,19,23)(H,20,21,22)

InChI Key

LBABLONYQBWPHH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19976390

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

373.36

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.457

Distribution Coefficient, logD

-0.496

Water Solubility, LogSw

-3.09

Polar Surface Area

66.245

Acid Dissociation Constant (pKa)

4.45

Base Dissociation Constant (pKb)

-2.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.70

V013-3335 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V013-3335 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V013-3335?
Check Price and Availability of V013-3335, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V013-3335 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V013-3335
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V013-3335
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V013-3335 available by request